Back to diagnoses

What is borderline personality disorder?

Borderline personality disorder (BPD) is a cluster B personality disorder characterized by emotional dysregulation, a pattern of unstable interpersonal relationships, and high impulsivity and recklessness. Its prevalence rate is 1.6-6%, but its rate can be as high as 20% in inpatient psychiatric care settings. BPD is more commonly diagnosed in women than in men.

What does borderline personality disorder look like?

Risk Factors

  • Childhood adversities - physical and sexual abuse, neglect, hostile conflict, early parental loss
  • First-degree relative with BPD (increases risk fivefold)

Differential Diagnosis

  • Identity problems
  • Depressive disorders
  • Bipolar disorders
  • Histrionic personality disorder
  • Schizotypal personality disorder
  • Antisocial personality disorder
  • Paranoid personality disorder
  • Narcissistic personality disorder
  • Dependant personality disorder
  • Personality changes due to another medical condition
  • Substance use disorders

Micropsychosis or Quasipsychosis

Micropsychosis is a psychotic episode that lasts for a very brief duration of time, such as for a few minutes to a few hours, and is usually triggered by heightened emotions or stress. Any auditory hallucinations would typically be negative in tone, and there could be dissociative symptoms.

How is borderline personality disorder treated?

Medications should not be considered for first-line treatment for borderline personality disorder. If used, the focus of the medications should be to target certain symptoms, and they should be for short-term relief.

According to a 2010 Cochrane Review, some medications are recommended for the following symptom clusters:

  • Interpersonal pathology:
    • Aripirazole, valproate, topiramate
  • Affective dysregulation:
    • Topiramate, lamotrigine, valproate, haloperidol, aripiprazole, olanzapine
  • Impulse-behavioral dyscontrol:
    • Topiramate, lamotrigine, flupentixol, aripiprazole, omega-3 fatty acids
  • Cognitive-perceptual:
    • Aripiprazole, olanzapine

Antipsychotics should not be used for medium- and long-term management of borderline personality disorder.

Nursing Management

Causes & Behaviors:

  • Desperate need for attention
  • Emotionally disturbed or battered children
  • Feelings of depression, rejection, self-hatred, separation anxiety, guilt, and depersonalization
  • History of self-injury
  • History of physical, emotional, or sexual abuse
  • High-risk populations, such as those with borderline personality disorder
  • Impulsive behavior
  • Inability to verbally express feelings (alexithymia)
  • Ineffective coping skills

Interventions:

  • Assess the client’s history of self-mutilation: types of mutilating behaviors, frequency behaviors, and stressors preceding behavior. Identifying patterns and circumstances surrounding self-injury can help with planning interventions and teaching strategies suitable to the client.

  • Identify feelings experienced before and around the act of self-mutilation.
    Feelings are a guideline for future intervention (e.g. rage at feeling left out or abandoned).

  • Explore with the client what these feelings might mean. Self-mutilation might also be a way to gain control, a way to feel alive through pain, or an expression of self-hate or guilt.
  • Secure a written or verbal no-harm/safety contract with the client. Identify specific steps (e.g. people to call upon when prompted to self-mutilate). The client is encouraged to take responsibility for healthier behavior. Talking to others and learning alternative coping skills can reduce frequency and severity until such behavior ceases.

  • Set and maintain limits on acceptable behavior and make clear the client’s responsibilities. If the client is hospitalized at the time, be clear regarding the unit rules. Clear and nonpunitive limit setting is essential for decreasing negative behaviors.

  • Be consistent in maintaining and enforcing the limits, using a nonpunitive approach. Consistency can establish a sense of security.

  • Use a matter-of-fact approach when self-mutilation occurs. Avoid criticizing or giving sympathy. A neutral approach prevents blaming, which increases anxiety, giving special attention that encourages acting out.

  • After the treatment of the wound, discuss what happened right before, and the thoughts and feelings that the client had immediately before self-mutilating. Identifies dynamics for both client and clinician. Allows the identification of less harmful responses to help relieve intense tensions.

  • Work out a plan identifying alternatives to self-mutilating behaviors. The plan is periodically reviewed and evaluated, and it offers a chance to deal with feelings and struggles that arise.


References

[1] American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA.

[2] Boyd, M. A. (2019). Psychiatric & mental health nursing for Canadian practice. Wolters Kluwer.

[3] Lieb, K., Völlm, B., Rücker, G., Timmer, A., & Stoffers, J. M. (2010). Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. The British Journal of Psychiatry, 196(1), 4–12.

[4] Schultz, H. E. & Hong, V. (2017). Psychosis in borderline personality disorder: How assessment and treatment differs from a psychotic disorder. Current Psychiatry, 16(4). 

[5] Townsend, M. C. (2015). Psychiatric mental health nursing. F.A. Davis.